PLEOMORPHISM

This adverse event was reported 15 times

PLEOMORPHISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0003
1 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 1 0.0002
2 HYOSCYAMINE SULFATE 1 0.0001
3 DASATINIB 1 0.0001
4 MUPIROCIN CALCIUM 1 0.0001
5 TACROLIMUS OINTMENT 0.1% 8 0.0001
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 8 0.0001
7 TACROLIMUS 8 0.0001
8 MYCOPHENILIC ACID 1 0.0000
9 MYCOPHENOLATE MOFETIL 6 0.0000
See all drugs enriched for association with PLEOMORPHISM